{Reference Type}: Journal Article
{Title}: Clinical, genetic characteristics and outcome of four Chinese patients with Bartter syndrome type 3: Further insight into a genotype-phenotype correlation.
{Author}: Piao Y;Chen C;Wu D;Liu M;Li W;Chen J;Sang Y;
{Journal}: Mol Genet Metab Rep
{Volume}: 40
{Issue}: 0
{Year}: 2024 Sep
{Factor}: 2.082
{DOI}: 10.1016/j.ymgmr.2024.101112
{Abstract}: UNASSIGNED: To investigate the characteristics of 4 Chinese patients with Bartter syndrome type 3 (BS Type 3).
UNASSIGNED: The clinical data, genetic analysis, and outcome of four cases with Bartter syndrome type 3 were retrospectively summarised.
UNASSIGNED: Gene sequencing analysis showed that all children carried a compound heterozygous mutation in the CLCNKB gene and were diagnosed with BS type 3. All types of mutations were detected, including two missense mutations, one nonsense mutation, one small fragment deletion mutation, two large deletion mutations and one splice-site mutation. The splice-site mutation c.100 + 1 (IVS2) C > T was novel. Two cases carried large deletion mutations. The patients presented as classic BS with modest manifestations. The most common sign was growth retardation. There was no polyhydramnios or preterm delivery. All cases were treated with potassium chloride supplementation and indomethacin. During long-term follow-up, clinical symptoms and growth retardation improved significantly. Nephrocalcinosis or renal dysfunction was not observed.
UNASSIGNED: The clinical manifestations of BS type 3 are mostly presented as cBS. Growth retardation is a common sign. BS type 3 had a good long-term prognosis. There were various types of mutations in the CLCNKB gene. Large deletions were the most common.